People prefer to swallow pills or drink tea than exercise to control their high blood pressure. A Yale study showed that only 1 in 3 Americans are interested in extending their life expectancy, even if there are options available. ( Christophe Archambault | Getty Images )
People would rather take a pill or drink a cup of coffee than exercise to lower blood pressure and live longer lives.
A study at the Yale School of Medicine surveyed 1,384 men and women and asked them which option they would choose if their lives would last another month, one year and five years. Participants are under 45 years old and have a history of hypertension.
Participants were asked to choose between pills, tea, exercise and monthly or biannual injections. Most of them, about 79 percent, chose the pill. The rate consequently increased to 90 and 96 percent if their lives were extended by one year and five years respectively.
Tea, which has antioxidant components, came in second with 78, 91 and 96 percent, respectively. Only 63 percent of the participants chose exercise as their main option, although the rate increased to 84 and 96 percent if their lives would be extended by another year and five years.
No to extended life
Study author Dr. Erica Spatz, badistant professor of cardiovascular medicine at the Center for Outcomes Research and Evaluation at Yale, concluded that only 1 in 5 Americans is interested in prolonging their hope of life by any means available.
The research, which was presented to the American Heart Association on Saturday, aimed to determine how people choose treatment options for cardiovascular risks if they have to weigh the benefits versus their drawbacks.
"Our findings show that people badign different weights to the advantages and disadvantages of interventions to improve cardiovascular health," Spatz said.
"I think we have to take advantage of this framework when we are talking to patients about the options for men to age their blood pressure, we are good at discussing side effects, but we rarely find out if other inconveniences or burdens may be affecting the disposition of a person to take a lifelong medication or exercise regularly. "
One in three Americans or 75 million people in the country have high blood pressure. The US Centers for Disease Control and Prevention UU They noted that only about half of them have their blood pressure controlled or controlled.
Hypertension accounts for more than 410,000 deaths in 2014 or 1,100 deaths per day. It translates into $ 48.6 billion in hospitalization, medications and related costs for the government and families of patients.
Meanwhile, an antihypertensive drug was presented that combines low doses of three drugs at the American College of Cardiology 2018 Annual Scientific Session.
The TRIUMPH trial, led by Dr. Ruth Webster of the University of New South Wales in Australia, was able to use the combined pill as eff The approach of low dose triple therapy since the initiation of antihypertensive treatment is appropriate for all parts of the world [the] since many patients do not reach target blood pressure everywhere, "Webster said.
However, the development of the drug is only the first phase." Webster said the real challenge is make the drug readily available to low and middle income people who are at risk for hypertension.
This novel approach, according to Webster, has been made by the medical community, although no definitive action was taken. new guidelines present, doctors can combine three different medications, even if the patient's blood pressure is not considered a hypertensive emergency.  © 2018 Tech Times, All rights reserved. Do not reproduce without permission.